Ultimately, Khan emphasized that protecting PHI requires more than compliance checkboxes—it demands a continuous, structured ...
By partnering with Surescripts, life sciences companies can tap into a vast network of health plans and pharmacy benefit ...
In the world of CGT products, change is the only constant. Whether it be new regulations, shifting reimbursement models, or evolving patient needs, a flexible channel strategy is table stakes and a ...
This case study explores how one pharmaceutical brand responded to a significant formulary loss, implementing seamless provider prior authorization strategies through CoverMyMeds to mitigate impact ...
The US Health Resources and Services Administration (HRSA) revealed the initial nine drugs to be included in the 340B rebate ...
This eBook, From Prescribing to Pick Up: Navigating the Access & Affordability Landscape, provides a focused view into CoverMyMeds’ access and affordability solutions and how they help biopharma ...
Real-time data and AI improve drug launch outcomes by identifying market gaps and enhancing patient access and engagement. Specialized expertise is essential for effective data integration, ensuring ...
Eli Lilly is investing $1.2 billion in its Puerto Rico site to enhance oral solid medicine production and integrate advanced technologies. The investment is part of Lilly's $50 billion strategy to ...
In the final part of her Pharma Commerce video interview, Jen Butler, CCO at Pleio, emphasizes that as digital tools become ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results